Stephen J.LurieMD, PhD, Contributing EditorIndividualAuthor
Copyright 2000 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2000
In Reply: These responses to our study raise
interesting points, but mainly serve to reinforce our conclusions, which are
that (1) eye screening is critically important, (2) high-risk patients should
receive annual screening, and, (3) low-risk patients (those with reasonable
risk factors and a previously normal eye examination) receive little to no
benefit from screening annually vs every 2 to 3 years. The discussion about
utility values highlights these points.
Fontanarosa PB, Vijan S, Hofer TP, Hayward RA. How Often Should Patients With Diabetes Be Screened for Retinopathy?—Reply. JAMA. 2000;284(4):437-439. doi:10.1001/jama.284.4.436